SOX9 and intrahepatic cholangiocarcinoma: However, SOX9 was not confirmed as a predictor of better survival in a different study [11], and not all molecular differentiation markers have a prognostic value: HNF1β, which is cholangiocyte-specific in adult liver and which stimulates biliary development [12], is not associated with survival rate of ICC [7, 13].